Abstract
The past few years have seen definite improvements in anti-inflammatory drugs. There are more compounds available. There are drugs which are much safer and better tolerated than the older anti-inflammatory drugs like aspirin. There are drugs which are much more convenient than aspirin, some of which can be taken as a single daily dose. There are drugs which act on some aspect of the disease process in rheumatoid arthritis and may alter the outcome of the disease. There are drugs for gout which make the management of this disease relatively easy and very successful. The future will certainly bring more drugs, although many will be similar to existing compounds. It would be good to see some different drugs. It would also be good to have treatments for osteoarthritis and rheumatoid arthritis which were as effective as the current treatment of gout.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 MTP Press Limited
About this chapter
Cite this chapter
Huskisson, E.C. (1980). Future trends in anti-rheumatic drugs. In: Willoughby, D.A., Giroud, J.P. (eds) Inflammation: Mechanisms and Treatment. Inflammation: Mechanisms and Treatment, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-9423-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-010-9423-8_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-9425-2
Online ISBN: 978-94-010-9423-8
eBook Packages: Springer Book Archive